TuHURA BIOSCIENCES, INC./NV Other Operating Income (Expense), Net
TuHURA BIOSCIENCES, INC./NV (HURA) reported Other Operating Income (Expense), Net of $49.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2024-11-14
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for the quarter ending 2024-09-30 was $49.00K, a 2350.00% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for the quarter ending 2024-06-30 was $61.00K, a 335.71% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for the quarter ending 2024-03-31 was $74.00K, a 89.74% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for the quarter ending 2023-12-31 was $2.00K, a 95.56% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for fiscal 2024 was $139.00K, a 1.46% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for fiscal 2023 was $137.00K, a 878.57% increase from fiscal 2022.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for fiscal 2022 was $14.00K.
- TuHURA BIOSCIENCES, INC./NV other operating income (expense), net for fiscal 2021 was -$26.00K, a 134.67% decline from fiscal 2020.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 3 month as first filed | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 6 month as first filed | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 9 month as first filed | Other Operating Income (Expense), Net 12 month | Other Operating Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $49.00K 10-Q · filed 2024-11-14 | $110.00K derived: sum of 2 quarters · filed 2024-11-14 | $184.00K derived: sum of 3 quarters · filed 2024-11-14 | $186.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-06-30 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $135.00K derived: sum of 2 quarters · filed 2024-10-07 | $137.00K derived: sum of 3 quarters · filed 2024-10-07 | $139.00K 10-K · filed 2024-10-07 | ||||
| 2024-03-31 | $74.00K 10-Q · filed 2024-05-14 | $76.00K derived: sum of 2 quarters · filed 2024-05-14 | $78.00K 10-Q · filed 2024-05-14 | $92.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | $2.00K 10-Q · filed 2024-02-14 | $4.00K 10-Q · filed 2024-02-14 | $18.00K derived: sum of 3 quarters · filed 2024-11-14 | $57.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-14 | $16.00K derived: sum of 2 quarters · filed 2024-11-14 | $55.00K derived: sum of 3 quarters · filed 2024-11-14 | $100.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $53.00K derived: sum of 2 quarters · filed 2024-10-07 | $98.00K derived: sum of 3 quarters · filed 2024-10-07 | $137.00K 10-K · filed 2024-10-07 | ||||
| 2023-03-31 | $39.00K 10-Q · filed 2024-05-14 | $84.00K derived: sum of 2 quarters · filed 2024-05-14 | $123.00K 10-Q · filed 2024-05-14 | $134.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $45.00K 10-Q · filed 2024-02-14 | $84.00K 10-Q · filed 2024-02-14 | $95.00K derived: sum of 3 quarters · filed 2024-02-14 | $96.00K derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $39.00K 10-Q · filed 2023-11-13 | $50.00K derived: sum of 2 quarters · filed 2023-11-13 | $51.00K derived: sum of 3 quarters · filed 2023-11-13 | $52.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18 | $12.00K derived: sum of 2 quarters · filed 2023-09-18 | $13.00K derived: sum of 3 quarters · filed 2023-09-18 | $14.00K 10-K · filed 2023-09-18 | ||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-11 | $2.00K derived: sum of 2 quarters · filed 2023-05-11 | $3.00K 10-Q · filed 2023-05-11 | -$3.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.00K 10-Q · filed 2023-02-14 | $2.00K 10-Q · filed 2023-02-14 | -$4.00K derived: sum of 3 quarters · filed 2023-02-14 | -$10.00K derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-09 | -$5.00K derived: sum of 2 quarters · filed 2022-11-09 | -$11.00K derived: sum of 3 quarters · filed 2022-11-09 | -$18.00K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$12.00K derived: sum of 2 quarters · filed 2022-09-27 | -$19.00K derived: sum of 3 quarters · filed 2022-09-27 | -$26.00K 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | -$6.00K 10-Q · filed 2022-05-13 | $1.00K 10-Q · filed 2021-05-13 | -$13.00K derived: sum of 2 quarters · filed 2022-05-13 | -$20.00K 10-Q · filed 2022-05-13 | $3.00K 10-Q · filed 2021-05-13 | -$19.00K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$7.00K 10-Q · filed 2022-02-11 | $1.00K 10-Q · filed 2021-02-12 | -$14.00K 10-Q · filed 2022-02-11 | $2.00K 10-Q · filed 2021-02-12 | -$13.00K derived: sum of 3 quarters · filed 2022-02-11 | $4.00K derived: sum of 4 quarters · filed 2022-02-11 | ||
| 2020-09-30 | -$7.00K 10-Q · filed 2021-11-15 | $1.00K 10-Q · filed 2020-11-12 | -$6.00K derived: sum of 2 quarters · filed 2021-11-15 | $11.00K derived: sum of 3 quarters · filed 2021-11-15 | $39.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $18.00K derived: sum of 2 quarters · filed 2021-09-28 | $46.00K derived: sum of 3 quarters · filed 2021-09-28 | $75.00K 10-K · filed 2021-09-28 | $75.25K 10-K · filed 2020-09-18 | |||
| 2020-03-31 | $17.00K 10-Q · filed 2021-05-13 | $16.96K 10-Q · filed 2020-05-13 | $45.00K derived: sum of 2 quarters · filed 2021-05-13 | $74.00K 10-Q · filed 2021-05-13 | $73.97K 10-Q · filed 2020-05-13 | $85.19K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $28.00K 10-Q · filed 2021-02-12 | $28.14K 10-Q · filed 2020-02-13 | $57.00K 10-Q · filed 2021-02-12 | $57.00K 10-Q · filed 2020-02-13 | $68.19K derived: sum of 3 quarters · filed 2021-02-12 | $81.59K derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-09-30 | $29.00K 10-Q · filed 2020-11-12 | $28.86K 10-Q · filed 2019-11-13 | $40.19K derived: sum of 2 quarters · filed 2020-11-12 | $53.59K derived: sum of 3 quarters · filed 2020-11-12 | $69.86K derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $11.19K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $24.59K derived: sum of 2 quarters · filed 2020-09-18 | $40.86K derived: sum of 3 quarters · filed 2020-09-18 | $60.70K 10-K · filed 2020-09-18 | -$60.70K 10-K · filed 2019-09-09 | |||
| 2019-03-31 | $13.40K 10-Q · filed 2020-05-13 | $29.67K derived: sum of 2 quarters · filed 2020-05-13 | $49.51K 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | $16.27K 10-Q · filed 2020-02-13 | $36.12K 10-Q · filed 2020-02-13 | ||||||
| 2018-09-30 | $19.84K 10-Q · filed 2019-11-13 | |||||||
| 2018-06-30 | -$33.24K 10-K · filed 2019-09-09 | |||||||
| 2017-06-30 | -$457.00 10-K · filed 2018-09-24 | |||||||
| 2016-06-30 | -$108.00 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |